Literature DB >> 9971840

Effect of immune priming on Borna disease.

A J Lewis1, J L Whitton, C G Hatalski, H Weissenböck, W I Lipkin.   

Abstract

Borna disease virus (BDV) is a neurotropic virus with a broad host and geographic range. Lewis rats were immunized against BDV with a recombinant vaccinia virus expressing the BDV nucleoprotein and were later infected with BDV to evaluate protection against Borna disease (BD). Relative to animals that were not immunized, immunized animals had a decreased viral burden after challenge with infectious virus, more marked inflammation, and aggravated clinical disease. These data suggest that a more robust immune response in Borna disease can reduce viral load at the expense of increased morbidity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9971840      PMCID: PMC104502     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Isolation and characterization of Borna disease agent cDNA clones.

Authors:  W I Lipkin; G H Travis; K M Carbone; M C Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Vaccination for disease.

Authors:  S Oehen; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1991-01-11       Impact factor: 47.728

Review 3.  Gene expression of nonsegmented negative strand RNA viruses.

Authors:  A K Banerjee; S Barik; B P De
Journal:  Pharmacol Ther       Date:  1991       Impact factor: 12.310

Review 4.  Borna disease: a persistent virus infection of the central nervous system.

Authors:  H Ludwig; L Bode; G Gosztonyi
Journal:  Prog Med Virol       Date:  1988

5.  Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.

Authors:  L S Klavinskis; J L Whitton; M B Oldstone
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation.

Authors:  K M Carbone; C S Duchala; J W Griffin; A L Kincaid; O Narayan
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

7.  Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.

Authors:  A Endo; S Itamura; H Iinuma; S Funahashi; H Shida; F Koide; K Nerome; A Oya
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

8.  Measles virus nucleocapsid protein protects rats from encephalitis.

Authors:  B Bankamp; U G Brinckmann; A Reich; S Niewiesk; V ter Meulen; U G Liebert
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

9.  Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.

Authors:  H G Morrison; S P Bauer; J V Lange; J J Esposito; J B McCormick; D D Auperin
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

10.  Borna disease, a progressive meningoencephalomyelitis as a model for CD4+ T cell-mediated immunopathology in the brain.

Authors:  J A Richt; L Stitz; H Wekerle; R Rott
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  10 in total

1.  Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant.

Authors:  Marco Henkel; Oliver Planz; Timo Fischer; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  Avian bornavirus associated with fatal disease in psittacine birds.

Authors:  Peter Staeheli; Monika Rinder; Bernd Kaspers
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

3.  Downregulation of an astrocyte-derived inflammatory protein, S100B, reduces vascular inflammatory responses in brains persistently infected with Borna disease virus.

Authors:  Naohiro Ohtaki; Wataru Kamitani; Yohei Watanabe; Yohei Hayashi; Hideyuki Yanai; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Inhibition of Borna disease virus replication by ribavirin.

Authors:  I Jordan; T Briese; D R Averett; W I Lipkin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage.

Authors:  Jürgen Hausmann; Axel Pagenstecher; Karen Baur; Kirsten Richter; Hanns-Joachim Rziha; Peter Staeheli
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Two major histocompatibility complex class I-restricted epitopes of the Borna disease virus p10 protein identified by cytotoxic T lymphocytes induced by DNA-based immunization.

Authors:  Yoshio Hashimoto; Horng-Shen Chen; Cynthia Cunningham; Tahir H Malik; Patrick K Lai
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Precursors of Borna disease virus-specific T cells in secondary lymphatic tissue of experimentally infected rats.

Authors:  Arvind Batra; Oliver Planz; Thomas Bilzer; Lothar Stitz
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

8.  Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.

Authors:  Marylou V Solbrig; Robert Schlaberg; Thomas Briese; Nigel Horscroft; W Ian Lipkin
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

9.  Viral vector vaccines expressing nucleoprotein and phosphoprotein genes of avian bornaviruses ameliorate homologous challenge infections in cockatiels and common canaries.

Authors:  Marita Olbert; Angela Römer-Oberdörfer; Christiane Herden; Sara Malberg; Solveig Runge; Peter Staeheli; Dennis Rubbenstroth
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

Review 10.  Avian Bornavirus Research-A Comprehensive Review.

Authors:  Dennis Rubbenstroth
Journal:  Viruses       Date:  2022-07-11       Impact factor: 5.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.